Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current HIV/AIDS Reports
Published in: Current HIV/AIDS Reports 2/2015

01-06-2015 | The Global Epidemic (SH Vermund, Section Editor)

Quality of Care and Service Expansion for HIV Care and Treatment

Authors: Carolyn Bolton Moore, Erica Ciaraldi

Published in: Current HIV/AIDS Reports | Issue 2/2015

Login to get access

Abstract

The last two decades have seen exceptional development of antiretroviral treatment programs throughout the world. Over 14 million persons are accessing antiretroviral treatment (ART) treatment as of early 2015, and life expectancy has risen markedly in the most-affected populations. However, large patient numbers threaten to overwhelm already over-burdened health care systems and retention in care remains suboptimal. Developing innovative strategies to alleviate these burdens and retain patients in care remains a challenge. Furthermore, despite this expansion, large populations of HIV-infected persons remain undiagnosed and are unwilling or unable to access care and treatment programs. Marginalized and high-risk populations are particularly in danger of remaining outside of care and are also disproportionately affected by HIV. To reverse the trend and “fast track” our way out of the epidemic, ambitious treatment targets are required, and a concerted effort has to be made to engage these populations into care, initiate ART, and attain viral suppression.
Literature
1.
WHO. Facts sheet HIV/AIDS. Geneva: World Health Organisation; 2014.
2.••
UNAIDS. Fast-track: ending the AIDS epidemic by 2030. Geneva: UNAIDS Information Production Unit; 2014. This report clearly shows the need to focus on marginalised and key populations in order to end the present AIDS Epidemic and gives clear guidance on targets and priorities.
3.
WHO. Consolidated ARV guidelines. Geneva: World Health Organisation; 2013.
4.
Ogbuagu O, Bruce RD. Reaching the unreached: treatment as prevention as a workable strategy to mitigate HIV and its consequences in high-risk groups. Curr HIV/AIDS Rep. 2014;11(4):505–12.CrossRefPubMed
5.
Cassell MM et al. 'Getting to zero' in Asia and the Pacific through more strategic use of antiretrovirals for HIV prevention. Sex Health. 2014;11(2):107–18.PubMed
6.
Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRefPubMedCentralPubMed
7.
Djomand G, Quaye S, Sullivan PS. HIV epidemic among key populations in west Africa. Curr Opin HIV AIDS. 2014;9(5):506–13.CrossRefPubMed
8.
Beattie TS et al. Community mobilization and empowerment of female sex workers in Karnataka State, South India: associations with HIV and sexually transmitted infection risk. Am J Public Health. 2014;104(8):1516–25.CrossRefPubMedCentralPubMed
9.
Thanh DC, Moland KM, Fylkesnes K. Persisting stigma reduces the utilisation of HIV-related care and support services in Viet Nam. BMC Health Serv Res. 2012;12:428.CrossRefPubMedCentralPubMed
10.
Rogers SJ et al. Testing a service integration model: results from the HIV/AIDS initiative, ConnectHIV. AIDS Care. 2013;25(3):317–25.PubMed
11.
12.
13.
Beyrer C. Pushback: the current wave of anti-homosexuality laws and impacts on health, 2014, PLOS Medicine. p. e1001658.
14.
Beyrer C, Abdool Karim Q. The changing epidemiology of HIV in 2013. Curr Opin HIV AIDS. 2013;8(4):306–10.PubMed
15.
Barnett-Vanes A. Criminalising homosexuality threatens the fight against HIV/AIDS. Lancet. 2014;1(383(9919)):783–4.CrossRef
16.
17.
Ifekandu C, Suleiman A, Aniekwe O. The cost-effectiveness in the use of HIV counselling and testing-mobile outreaches in reaching men who have sex with men (MSM) in northern Nigeria. J Int AIDS Soc. 2014;17(4 Suppl 3):19610.PubMedCentralPubMed
18.
Young AM et al. Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis. AIDS Behav. 2014;18(9):1753–63.CrossRefPubMed
19.
20.
Woolf-King SE et al. Substance use and HIV risk behavior among men who have sex with men: the role of sexual compulsivity. J Urban Health. 2013;90(5):948–52.CrossRefPubMedCentralPubMed
21.
Surratt HL et al. HIV testing and engagement in care among highly vulnerable female sex workers: implications for treatment as prevention models. J Health Care Poor Underserved. 2014;25(3):1360–78.CrossRefPubMed
22.
Chersich MF et al. Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services. J Int AIDS Soc. 2013;16:17980.CrossRefPubMedCentralPubMed
23.
Scorgie F et al. Human rights abuses and collective resilience among sex workers in four African countries: a qualitative study. Global Health. 2013;9(1):33.CrossRefPubMedCentralPubMed
24.
Mountain E et al. Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis. PLoS ONE. 2014;9(9):e105645.CrossRefPubMedCentralPubMed
25.
Ti L, Kerr T. Task shifting redefined: removing social and structural barriers to improve delivery of HIV services for people who inject drugs. Harm Reduct J. 2013;10:20.CrossRefPubMedCentralPubMed
26.
Chakrapani V et al. Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai. South India AIDS Care. 2014;26(7):835–41.CrossRef
27.
Westergaard RP et al. Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS. 2013;27(16):2559–66.CrossRefPubMedCentralPubMed
28.
Dvoriak S et al. Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response. Drug Alcohol Depend. 2014;137:62–7.CrossRefPubMedCentralPubMed
29.
MacArthur GJ et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.CrossRefPubMedCentralPubMed
30.
Bachireddy C et al. Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend. 2014;134:106–14.CrossRefPubMed
31.
Green A et al. Clinical mentorship of nurse initiated antiretroviral therapy in Khayelitsha, South Africa: a quality of care assessment. PLoS ONE. 2014;9(6):e98389.CrossRefPubMedCentralPubMed
32.
Zuber A et al. A survey of nurse-initiated and -managed antiretroviral therapy (NIMART) in practice, education, policy, and regulation in east, central, and southern Africa. J Assoc Nurses AIDS Care. 2014;25(6):520–31.CrossRefPubMed
33.
Emdin CA, Chong NJ, Millson PE. Non-physician clinician provided HIV treatment results in equivalent outcomes as physician-provided care: a meta-analysis. J Int AIDS Soc. 2013;16:18445.CrossRefPubMedCentralPubMed
34.
35.
Kredo T et al. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy. Cochrane Database Syst Rev. 2014;7:CD007331.PubMed
36.
Boyer S et al. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS. 2010;24 Suppl 1:S5–S15.CrossRefPubMed
37.••
Bemelmans M et al. Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Trop Med Int Health. 2014;19(8):968–77. This article, which looks at four new and different approaches to simplify ART service delivery for stable patients, shares critical information on the economic, social, and health benefits of different community ART models.CrossRefPubMed
38.•
Suthar AB et al. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. AIDS. 2014;28 Suppl 2:S175–85. This review provides strong evidence for the integration of ART into different service delivery settings, including MCH, TB and OST services in order to improve retention in care.CrossRefPubMed
39.
Kredo T, Ford N, Adeniyi FB, Garner P. Decentralising HIV treatment in lower-and middle-income countries. Sao Paulo Med J. 2014;132(6):383.CrossRef
40.
Fayorsey RN et al. Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries. J Acquir Immune Defic Syndr. 2013;62(5):e124–30.CrossRefPubMed
41.
Grimsrud A et al. Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs. J Acquir Immune Defic Syndr. 2014;67(2):e55–66.CrossRefPubMed
42.
Grimsrud A et al. Extending dispensing intervals for stable patients on ART. J Acquir Immune Defic Syndr. 2014;66(2):e58–60.PubMed
43.
Suthar AB et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med. 2013;10(8):e1001496.CrossRefPubMedCentralPubMed
44.
Fatti G, Meintjes G, Shea J, Eley B, Grimwood A. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. JAIDS J Acquir Immune Defic Syndr. 2012;61(4):50–8.CrossRef
45.
Wouters E, Van Damme W, van Rensburg D, Masquillier C, Meulemans H. Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review. BMC Health Serv Res. 2012;12(1):194.CrossRefPubMedCentralPubMed
46.
Mwai GW, Mburu G, Torpey K, Frost P, Ford N, Seeley J. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc, 2013. 16(1).
47.
Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, Rich ML. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. Clin Infect Dis, 2012. 1193.
48.
Decroo T et al. Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique. Trop Med Int Health. 2014;19(5):514–21.CrossRefPubMed
49.
Rasschaert F et al. Sustainability of a community-based anti-retroviral care delivery model - a qualitative research study in Tete, Mozambique. J Int AIDS Soc. 2014;17:18910.CrossRefPubMedCentralPubMed
50.
Rasschaert F et al. Adapting a community-based ART delivery model to the patients' needs: a mixed methods research in Tete, Mozambique. BMC Public Health. 2014;14:364.CrossRefPubMedCentralPubMed
51.
Luque-Fernandez MA et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS ONE. 2013;8(2):e56088.CrossRefPubMedCentralPubMed
52.•
Duncombe C. et al. Reframing HIV care: putting people at the centre of antiretroviral delivery. Trop Med Int Health, 2015. This article describes the need for a revised delivery framework which provides focused, differentiated services which are tailored for specific populations in an attempt to improve the quality of care provided, increase access to care and improve efficiencies, retention and adherence.
53.
Leon N, Schneider H, Daviaud E. Applying a framework for assessing the health system challenges to scaling up mHealth in South Africa. BMC Med Inform Decis Mak. 2012;12(1):123.CrossRefPubMedCentralPubMed
54.
Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa. BMC Public Health. 2014;14(1):188.CrossRefPubMedCentralPubMed
55.
Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS ONE. 2014;9(2):e88166.CrossRefPubMedCentralPubMed
56.
Finocchario-Kessler S et al. If you text them, they will come: using the HIV infant tracking system to improve early infant diagnosis quality and retention in Kenya. AIDS. 2014;28 Suppl 3:S313–21.CrossRefPubMedCentralPubMed
57.
Horvath T et al. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;3:CD009756.PubMed
58.
Odeny TA et al. Integration of HIV care with primary health care services: effect on patient satisfaction and stigma in rural Kenya. AIDS Res Treat. 2013;2013:485715.PubMedCentralPubMed
59.
Mbuagbaw L et al. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS ONE. 2012;7(12):e46909.CrossRefPubMedCentralPubMed
60.
Odeny TA et al. Developing content for a mHealth intervention to promote postpartum retention in prevention of mother-to-child HIV transmission programs and early infant diagnosis of HIV: a qualitative study. PLoS ONE. 2014;9(9):e106383.CrossRefPubMedCentralPubMed
61.
Smillie K, Borek NV, Kop MLVD, Lukhwaro A, Li N, Karanja S, et al. Mobile health for early retention in HIV care: a qualitative study in Kenya (WelTel Retain). Afr J AIDS Res. 2014;13(4):331–8.CrossRefPubMed
62.
Smillie K et al. A qualitative study investigating the use of a mobile phone short message service designed to improve HIV adherence and retention in care in Canada (WelTel BC1). J Assoc Nurses AIDS Care. 2014;25(6):614–25.CrossRefPubMed
63.
Horvath KJ et al. Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav. 2012;16(4):900–10.CrossRefPubMedCentralPubMed
64.
Horvath KJ et al. Strategies to retain participants in a long-term HIV prevention randomized controlled trial: lessons from the MINTS-II study. AIDS Behav. 2012;16(2):469–79.CrossRefPubMedCentralPubMed
65.
Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl), 2013. 5(1).
66.
Muessig KE, Nekkanti M, Bauermeister J, Bull S, Hightow-Weidman LB. A systematic review of recent smartphone, Internet and web 2.0 interventions to address the HIV continuum of care. Curr HIV/AIDS Rep, 2015. 1-18
67.
Hung A, Pradel F. A review of how the quality of HIV clinical services has been evaluated or improved. Int J STD AIDS, 2014.
68.
Bhardwaj S et al. Elimination of mother-to-child transmission of HIV in South Africa: rapid scale-up using quality improvement. S Afr Med J. 2014;104(3 Suppl 1):239–43.CrossRefPubMed
69.
Ciampa PJ et al. Addressing poor retention of infants exposed to HIV: a quality improvement study in rural Mozambique. J Acquir Immune Defic Syndr. 2012;60(2):e46–52.CrossRefPubMedCentralPubMed
Metadata
Title
Quality of Care and Service Expansion for HIV Care and Treatment
Authors
Carolyn Bolton Moore
Erica Ciaraldi
Publication date
01-06-2015
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 2/2015
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-015-0263-y

Other articles of this Issue 2/2015

Current HIV/AIDS Reports 2/2015 Go to the issue

The Global Epidemic (SH Vermund, Section Editor)

Sustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention Approaches

Central Nervous System and Cognition (SS Spudich, Section Editor)

Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered

Central Nervous System and Cognition (SS Spudich, Section Editor)

Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS

The Global Epidemic (SH Vermund, Section Editor)

Implementation Research for the Prevention of Mother-to-Child HIV Transmission in Sub-Saharan Africa: Existing Evidence, Current Gaps, and New Opportunities

Central Nervous System and Cognition (SS Spudich, Section Editor)

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy

The Global Epidemic (SH Vermund, Section Editor)

A Political and Social History of HIV in South Africa
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits